MR-Center, University Children's Hospital Zurich, Zurich, Switzerland.
Ann Neurol. 2009 Dec;66(6):858-61. doi: 10.1002/ana.21801.
Transcranial magnetic resonance (MR)-guided high-intensity focused ultrasound (tcMRgHIFU) implies a novel, noninvasive treatment strategy for various brain diseases. Nine patients with chronic neuropathic pain were treated with selective medial thalamotomies. Precisely located thermal ablations of 4mm in diameter were produced at peak temperatures of 51 degrees C to 60 degrees C under continuous visual MR guidance and MR thermometry. The resulting lesions are clearly visible on follow-up MR imaging. All treatments were well tolerated, without side effects or neurological deficits. This is the first report on successful clinical application of tcMRgHIFU in functional brain disorders, portraying it as safe and reliable for noninvasive neurosurgical interventions.
经颅磁共振(MR)引导高强度聚焦超声(tcMRgHIFU)为各种脑部疾病提供了一种新颖的、非侵入性的治疗策略。9 名患有慢性神经性疼痛的患者接受了选择性内侧丘脑切开术治疗。在连续的磁共振视觉引导和磁共振测温下,产生了直径为 4 毫米的精确定位热消融,峰值温度为 51°C 至 60°C。在后续的磁共振成像上可以清楚地看到这些病变。所有治疗均耐受良好,无副作用或神经功能缺损。这是 tcMRgHIFU 在功能性脑疾病中成功临床应用的首次报道,表明其用于非侵入性神经外科干预是安全可靠的。